Forum Discussion

Community Manager

4 years ago

Trodelvy approved for PBS

BCNA welcomes yesterday's announcement to list Trodelvy® (sacituzumab govitecan) to the Pharmaceutical Benefits Scheme (PBS). Check out the article for full details of this news and eligibility https://www.bcna.org.au/news/2022/03/trodelvy-approved-for-pbs/

metastatic-breast-cancer

pharmaceutical-benefits-scheme

treatment-options

brightspace
Member
4 years ago
Super news everyone 👏😊
Mez_BCNA
Community Manager
4 years ago
Here is the channel 9 news article if you missed it https://www.9news.com.au/national/federal-budget-2022-breast-cancer-drug-trodelvy-listed-pharmaceutical-benefits-scheme/d4f261e6-ad46-4337-a79f-0c62e5ae9123
iserbrown
Member
4 years ago
Excellent news!

Forum Discussion

Trodelvy approved for PBS

Related Content

Trodelvy - any info to share?

CDK Inhibitors approved by PBAC 20 April 2018

America's FDA approves yet another drug

Cancer Drugs Approved Quickly Often Fail To Measure Up Later

TGA approval for OTC sale of melatonin to adults 55+ from 01 June 2021

Recent Discussions

How long the side effects can last?

Surgery Decision

Ca 125 test

Oncotype DX testing

Struggling with Tamoxifen side effects

Disclaimer:

Foundation partner	Major partners